ER-positive breast cancer cells are poised for RET-mediated endocrine resistance

The RET tyrosine kinase signaling pathway is involved in the development of endocrine resistant ER+ breast cancer. However, we know little about how ER+ cells activate RET signaling and initiate an endocrine resistant phenotype. Here we show that both ER+ endocrine resistant and sensitive breast can...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Horibata, Sachi, Rice, Edward J., Mukai, Chinatsu, Marks, Brooke A., Sams, Kelly, Zheng, Hui, Anguish, Lynne J., Coonrod, Scott A., Danko, Charles G.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5880349/
https://ncbi.nlm.nih.gov/pubmed/29608602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194023
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg